iHuman Inc. ADR (IH): Price and Financial Metrics
IH Price/Volume Stats
|Current price||$3.02||52-week high||$4.26|
|Prev. close||$2.91||52-week low||$1.34|
|Day high||$3.02||Avg. volume||18,523|
|50-day MA||$3.11||Dividend yield||N/A|
|200-day MA||$3.09||Market Cap||160.49M|
IH Stock Price Chart Interactive Chart >
iHuman Inc. ADR (IH) Company Bio
iHuman, Inc. operates as a childhood edutainment company in China, with core expertise in providing integrated and innovative products and services catering to education needs at school and at home, covering online and offline. The company was founded by Yu Feng Chi in March 2016 and is headquartered in Beijing, China.
IH Latest News Stream
|Loading, please wait...|
IH Latest Social Stream
View Full IH Social Stream
Latest IH News From Around the Web
Below are the latest news stories about IHUMAN INC that investors may wish to consider to help them evaluate IH as an investment opportunity.
Ms. Vivien Wang, Director and Chief Financial Officer (CFO) of iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, was recognized as "CFO of the Year 2022-2023" in the 2022-2023 Financial Performance Awards (the "Awards") presented by North American Business. This prestigious honor is a clear indication of how the capital markets recognize and value the exceptional leadership capabilities of iHuman's management team.
Key Insights Insiders appear to have a vested interest in iHuman's growth, as seen by their sizeable ownership 55% of...
The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by...
Although people might not readily recognize these little-known stocks, they offer surprisingly robust upside potential.
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2023.
IH Price Returns